Press Releases from Apixaban Market - Size, Share, Outlook, and Forecast till 2026 (1 total)
Apixaban Market - Size, Share, Outlook, and Forecast till 2026
Apixaban is an anticoagulant used to reduce blood clotting and risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is an oral factor Xa inhibitor and is sold under the trade name Eliquis. It was approved in Europe in 2012 and in the U.S. in 2014 for treatment and secondary prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE). Apixaban was developed in a joint…
